Search

everythinglearnresearchcommunity

for

Search:↓

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Erlotinib can cause excessive eyelash growth.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The extract of Silybum marianum, Manganese PCA, and Lespedeza capitata can boost hair growth and extend the growth phase when combined in a serum.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

Tideglusib helps heal wounds in older skin.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

The plant extracts may help treat hair loss by promoting hair growth and reducing DHT levels.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Afatinib often causes skin problems that need proactive management.

EGFR hyperactivation increases sebaceous gland size and sebum production in mice.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

AP-1 controls tumor cell type by affecting key signaling pathways.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Fingerprints form uniquely before birth due to specific genetic pathways and local signals.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Alpha 6 + /MHCI - cells have stem cell traits and are similar to mouse hair follicle stem cells.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.